CONDENSED HETEROCYCLIC DERIVATES AS BCL-2 INHIBITORS FOR THE TREATMENT OF NEOPLASTIC DISEASES

• 收藏
• 分享

专利权人:

Newave Pharmaceutical Inc.

发明人:

Yi Chen,Yan Lou

申请号：

US16795884

公开号：

US20200190109A1

申请日:

2020.02.20

申请国别(地区):

US

年份:

2020

代理人:

摘要：

The disclosure includes compounds of Formula (A):wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, and R12, j, k, m, n, Y, W, W1, W2, W3, V, L, Z1, Q1, Q2, Q3, and Q4, are defined herein. Also disclosed is a method for treating a neoplastic disease, an autoimmune disease, or a neorodegenerative disease with these compounds.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/